ProFibrix BV, a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, has raised $11 million in Series A funding led by Index Ventures. www.profibrix.com
ProFibrix BV, a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, has raised $11 million in Series A funding led by Index Ventures. www.profibrix.com
Copyright PEI Media
Not for publication, email or dissemination